Entries by Andrew Horn

TFND Webinar Series: Policy

On January 20, TFND executive Director Heather Austin led a webinar on how to work on tobacco policy in North Dakota. That video can be viewed by clicking here.

CTFK: North Dakota Ranks top-5 in Funding for Tobacco Control Program

Campaign for Tobacco Free Kids released its state by state look at tobacco control funding. North Dakota ranks 5th nationally for funding at 58 percent of the CDC recommended level. North Dakota’s legislature increased tobacco control funding during the 2021 legislative session. You can read the report here.

NDSU: E-Liquid Labels Don’t Match Contents

North Dakota State University’s Kelly Buettner-Schmidt has also done multiple studies proving the contents of e-liquid containers don’t match the labels. Below is an excerpt to a summary of the piece: “In December 2021, the North Dakota State University Tobacco Control and Prevention Research Team published an article1 in the journal, The Nurse Practitioner. I […]

Almost Half of Lung Cancer Patients Still Smoked After Surgery

Tobacco addiction is an addiction. It is hard for people to quit, especially on the first try. This article shows many who’ve gone through surgical treatment found there way back to tobacco after a year. To read the article, click here

Johns Hopkins finds thousands of unknown chemicals in e-cigarettes

A recent Johns Hopkins study found thousands of previously undetected chemicals in vapor from e-products. Previous studies of e-cigarettes have looked specifically for evidence of the hazardous chemicals found in traditional cigarettes. But here the researchers performed a non-targeted analysis to explore the full range of chemicals both in the vaping liquid and the aerosols. […]

FDA Permits Marketing of E-Cigarette Products

The FDA approved marketing for 3 e-cigarette products on Tuesday, marking the first approvals under the new Premarket Tobacco Product Application (PMTA) pathway. TFND does not support the agency’s decision. Executive Director Heather Austin released this statement in response to the FDA’s decision: “We are deeply concerned about the 3 products newly designated by the […]